Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

CORAL GABLES, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst's management team, will participate in the upcoming investor conferences detailed belo

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

• 
  Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

  Zacks
• 
  Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

  Zacks